4.8 Review

Malaria: Biology and Disease

Journal

CELL
Volume 167, Issue 3, Pages 610-624

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2016.07.055

Keywords

-

Funding

  1. National Health and Medical Research Council of Australia
  2. PATH/MVI
  3. USAID
  4. Wellcome Trust

Ask authors/readers for more resources

Malaria has been a major global health problem of humans through history and is a leading cause of death and disease across many tropical and subtropical countries. Over the last fifteen years renewed efforts at control have reduced the prevalence of malaria by over half, raising the prospect that elimination and perhaps eradication may be a long-term possibility. Achievement of this goal requires the development of new tools including novel antimalarial drugs and more efficacious vaccines as well as an increased understanding of the disease and biology of the parasite. This has catalyzed a major effort resulting in development and regulatory approval of the first vaccine against malaria (RTS, S/AS01) as well as identification of novel drug targets and antimalarial compounds, some of which are in human clinical trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available